A HYBRID CONFERENCE AND INTERNET EVENT

25th Annual Pharmaceutical
and Medical Device Ethics
and Compliance Congress

October 28-30, 2024

Hybrid Onsite Conference & Internet Event — Live and Archived
Grand Hyatt Washington
Washington, DC

Follow Pharma Congress on:  


Terri L. Ledva, MS

Director, Ethics & Compliance, Aurobindo Pharma LTD; Former Senior Manager Compliance, Iroko Pharmaceuticals LLC, Philadelphia, PA

Victoria A. Lipnic, JD

Partner, Head of Human Capital Strategy Group, Resolution Economics; Former Commissioner & Acting Chair, US EEOC, Washington, DC

Cristina List, CPA, CCEP

Director, Compliance Advisory Services, MedPro Systems; Former Compliance Officer, Carestream, Mount Arlington, NJ

Kirsten Liston

Principal & Founder, Rethink Compliance; Co-author, The Compliance Entrepreneur’s Handbook, Denver, CO

Elaina McEwan

Director, Life Sciences Consulting Group, Litigation Department, Paul Hastings, New York, NY

Rosemary McKenna, JD

Director, Regulatory Legal, Organon; Former Director, Regulatory Legal, Merck, Philadelphia, PA

Robert Melillo, JD

Co-founder and Managing Director, G&M Health; Former Vice President & Managing Director, Compliance Management and Commercial Services, PRS Franklin, an inVentiv Health Company, Frenchtown, NJ

Gregory S. Moss, LLB

Chief Business and Legal Officer, Corporate Secretary and Chief Compliance Officer, Evommune, Inc., New York, NY

Christine A. Moundas, MPH, JD

Partner, Ropes & Gray, LLP; Former Analyst, HHS, New York, NY

Patrick Murphy, JD

SVP Global Head Litigation & Investigations, Fresenius Medical Care; Former General Counsel, Litigation, GE Healthcare, Washington, DC

Brooke Nelson, JD

Vice President, Ethics & Business Integrity, North America & Global Specialty Care, Sanofi, Los Angeles, CA

Katherine C. Norris, MPA

Senior Managing Director, Ankura; Former Senior Director, Compliance & Integrity Programs, NSF Health Sciences, Washington, DC

Daniel O’Connor

SVP, NXLevel Compliance; Former VP, Learning & Development, Morgan Stanley, New York, NY

Adam Oakley

Senior Director, Potomac River Partners, Washington, DC

Kirk Ogrosky, JD

Partner and Co-Chair, Healthcare Government Enforcement, Goodwin Procter LLP; Deputy Chief, Fraud Section, Criminal Division, US DOJ, Washington, DC

John Oroho, JD

President and General Manager, RLDatix Life Sciences; Of Counsel, Porzio, Bromberg & Newman, Morristown, NJ

Gus Papandrikos, MBA

Global Head of Compliance Assurance, Daiichi Sankyo; Former Senior Head, Compliance Operations, Global Compliance & Risk Management, Shire, New York, NY

Garrett Pape, JD

Senior Manager, Forensic & Integrity Services, EY, Chicago, IL

Mark Pearson, MBA

Principal, Deloitte, Chicago, IL

Danielle Pelot, JD

Partner, Choate Hall & Stewart, Boston, MA

Kristen Perriello, JD

Principal, Choate, Hall & Stewart, LLP; Former Special Assistant District Attorney, Suffolk County District Attorney’s Office, Boston, MA

Saraswatha Putcha, MA

Associate Director, Global Risk Assessment & Monitoring, Cresen Solutions, Philadelphia, PA

John S. Rah, JD

Counsel, Potter & Murdock, Potomac, MD

David Ralston, JD

Managed Care Attorney Consultant; Market Access Legal Specialist, Biogen and Rocket Pharmaceuticals, Boston, MA

Nikki Reeves, JD

Partner & Co-chair, Life Sciences & Healthcare Industry Group, King & Spalding, Washington, DC

Omar Richardson, MBA

Senior Director of Compliance, Shionogi; Former Compliance Officer, Grünenthal Group; Former Director, Corporate Compliance, Indivior, New York, NY

Timothy Roberts, MA

Global Chief Compliance Officer, Legend Biotech; Former US Compliance & Privacy Officer, Ferring, Mendham, NJ

Tad Roselund

Managing Director & Senior Partner and Former Chief Risk Officer, The Boston Consulting Group, Montclair, NJ

Elan Schefflein, JD

Senior Compliance Advisor, MedPro Systems, New York, NY

Sulin Shah, JD

Law Offices of Sulin Shah; Legal Consultant, Soleno Therapeutics; Former VP, US General Counsel, PharmaEssentia & Orphazyme A/S, Chicago, IL

John Shakow, JD

Partner, King & Spalding LLP, Washington, DC

Alexis Shaw

Deputy Chief Compliance Officer, Paratek; Former Compliance Officer, Endo, Malvern, PA

Michael L. Shaw, JD

Global Head of Compliance, Privacy & Risk, ZS; Former VP & Compliance Officer, GlaxoSmithKline; Former Senior Counsel, HHS OIG, Princeton, NJ

Paul Silver

Corporate Intelligence Services Practice Leader, Life Sciences Regulatory, Legal, & Compliance Leader, Deloitte Advisory, Atlanta, GA

Sara R. Simon, JD

Counsel, Porzio, Bromberg & Newman; Former Director, US Health Care Compliance Certification Program, Seton Hall University School of Law, Morristown, NJ

Laura A. Skinner, MBA

Managing Director, Life Sciences Consulting Group, Paul Hastings, New York, NY

Mike Stanek, JD

Associate Vice President, Assistant General Counsel, Eli Lilly and Company, Indianapolis, IN

Keren Tenenbaum, JD

US General Counsel and Chief Compliance Officer, Ascendis; Former GC, VP, Legal & Compliance, US, Vifor, New York, NY

Kelly J. Tope, JD, MBA

Head of USBU Ethics & Compliance Monitoring & Reporting Operations, Takeda; Former Global Director, Compliance, Transparency, Monitoring, Biomet, Boston, MA

Natasha Trifun, JD

Executive Director, Head of Compliance, R&D, Global Medical, External Funding & Global Functions, Alexion, AstraZeneca Rare Disease, Boston, MA

Manny Tzavlakis

Managing Partner, HELIO, Morristown, NJ

Erin Vales

Principal Consultant, Cresen Solutions, Richmond, VA

L. Stephan Vincze, JD, LLM, MBA

President & CEO, TRESTLE Compliance; Former SVP and CCO, Warner Chilcot; Former VP, Ethics and Compliance Officer, TAP Pharmaceutical, Boston, MA

Seth Whitelaw, JD

President and Chief Executive Officer, Whitelaw Compliance Group, Philadelphia, PA

Constance A. Wilkinson, JD

Board of Directors, Member of the Firm, Epstein Becker & Green, P.C., Washington, DC

Tyler Wiseman, MBA, JD

Chief Legal Officer, Elevar Therapeutics; Former Corporate Counsel, Praxis Precision Medicines, Boston, MA

Ronald L. Wisor, Jr, JD

Partner, Lifesciences & Healthcare, Hogan Lovells, Washington, DC

Meghan Zalasky

Associate Manager, Regulatory Account Lead, Global Transparency, RLDatix Life Sciences, Hackettstown, NJ



FEATURING THE PHARMA & MEDICAL DEVICE CONGRESS ADVANCED VIRTUAL INTERACTIVE VIDEO BROADCAST PORTAL

Featuring one-on-one attendee video chat and large group video interactive workshops.
See last year’s Congress portal: